12S133: Abstracts: Systemic Sclerosis and Related Disorders – Clinical I: Trials and Therapeutics (0518–0523)

Abstract Moderator(s)

• 

  Jessica Gordon, MD, MSc

  Hospital for Special Surgery
  New York, NY, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Francesco Boin, MD

  Cedars-Sinai Medical Center
  Los Angeles, CA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 3:00 PM – 3:10 PM Eastern Time

  Changes in Skin Fibroblast Polarization Gene Expression Herald Clinical Improvement in Early, Diffuse Cutaneous Systemic Sclerosis
  

  Presenting Author: Kimberly S. Lakin, MD, MS – Hospital for Special Surgery
• 3:10 PM – 3:15 PM Eastern Time

  Q&A
  
• 3:15 PM – 3:25 PM Eastern Time

  Myeloablation Followed by Hematopoietic Stem Cell Transplantation Leads to Long-term Normalization of Systemic Sclerosis Molecular Signatures
  

  Presenting Author: Nancy Wareing, BS – UTHealth Houston McGovern Medical School
• 3:25 PM – 3:30 PM Eastern Time

  Q&A
  
• 3:30 PM – 3:40 PM Eastern Time

  Combination Therapy of Mycophenolate Mofetil and Pirfenidone vs. Mycophenolate Alone: Results from the Scleroderma Lung Study III
  

  Presenting Author: Dinesh Khanna, MD, MSc – University of Michigan
• 3:40 PM – 3:45 PM Eastern Time

  Q&A
  
• 3:45 PM – 3:55 PM Eastern Time

  Examination of Differential Response to Treatment with Mycophenolate Mofetil in Black and White Patients with Systemic Sclerosis
  

  Presenting Author: Lauren Smith, MD – Johns Hopkins
• 3:55 PM – 4:00 PM Eastern Time

  Q&A
  
• 4:00 PM – 4:10 PM Eastern Time

  Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis from EUSTAR
  

  Presenting Author: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
• 4:10 PM – 4:15 PM Eastern Time

  Q&A
  
• 4:15 PM – 4:25 PM Eastern Time

  The Development of the Ranked Composite Important Difference in Diffuse Cutaneous Systemic Sclerosis; A Clinical and Patient Meaningful Anchor to the ACR-Composite Response Index in SSc
  

  Presenting Author: Francesco Del Galdo, MD, PhD – University of Leeds
• 4:25 PM – 4:30 PM Eastern Time

  Q&A